Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02)

Clinical trial NCT00235482 · COMPLETED

Trial details

NCT number: NCT00235482
Sponsor: Viralytics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2005-11-08
Primary completion: 2006-04-21
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.